Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

N Wagner; MM Lenders; K Kuhl; L Reinhardt; M Fuchss; N Ring; Georg Richtig; C Ebel; F Andre; R Stager; C Zellweger; SH Sturmer; R Lang; M Paar; P Gussek; S Kimeswenger; A Oellinger; T Amaral; A Forschner; U Leiter-Stoppke; B Weide; M Gassenmaier; A Schraag; B Klumpp; W Hoetzenecker; M Ziemer; C Berking; J Mangana; VA Nguyen; P Terheyden; Erika Richtig; C Loquai; S Diem; A Cozzio; M Rocken; C Garbe; C Gebhardt; F Meier; T Eigentler; L Flatz

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

N Wagner
, MM Lenders
, K Kuhl
, L Reinhardt
, M Fuchss
, N Ring
, Georg Richtig
, C Ebel
, F Andre
, R Stager
, C Zellweger
, SH Sturmer
, R Lang
, M Paar
, P Gussek
, S Kimeswenger
, A Oellinger
, T Amaral
, A Forschner
, U Leiter-Stoppke

B Weide, M Gassenmaier, A Schraag, B Klumpp, W Hoetzenecker, M Ziemer, C Berking, J Mangana, VA Nguyen, P Terheyden, Erika Richtig, C Loquai, S Diem, A Cozzio, M Rocken, C Garbe, C Gebhardt, F Meier, T Eigentler, L Flatz

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	JDDG - Journal of the German Society of Dermatology
Publication status	Published - 2022
Event	32. Deutscher Hautkrebskongress - Hannover, Germany Duration: 14 Sept 2022 → 17 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

Links

Web of Science

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice
Wagner, N. (Author), Lenders, M. (Author), Kuhl, K. (Author), Reinhardt, L. (Author), Fuchss, M. (Author), Ring, N. (Author), Richtig, G. (Author), Ebel, C. (Author), Andre, F. (Author), Stager, R. (Author), Zellweger, C. (Author), Sturmer, S. (Author), Lang, R. (Author), Paar, M. (Author), Gussek, P. (Author), Kimeswenger, S. (Author), Oellinger, A. (Author), Amaral, T. (Author), Forschner, A. (Author), Leiter-Stoppke, U. (Author), Weide, B. (Author), Gassenmaier, M. (Author), Schraag, A. (Author), Klumpp, B. (Author), Hoetzenecker, W. (Author), Ziemer, M. (Author), Berking, C. (Author), Mangana, J. (Author), Nguyen, V. (Author), Terheyden, P. (Author), Richtig, E. (Author), Loquai, C. (Author), Diem, S. (Author), Cozzio, A. (Author), Rocken, M. (Author), Garbe, C. (Author), Gebhardt, C. (Author), Meier, F. (Author), Eigentler, T. (Author) & Flatz, L. (Author)
2022
Activity: Talk, presentation or poster › Poster

Cite this

Wagner, N., Lenders, MM., Kuhl, K., Reinhardt, L., Fuchss, M., Ring, N., Richtig, G., Ebel, C., Andre, F., Stager, R., Zellweger, C., Sturmer, SH., Lang, R., Paar, M., Gussek, P., Kimeswenger, S., Oellinger, A., Amaral, T., Forschner, A., ... Flatz, L. (2022). Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice. JDDG - Journal of the German Society of Dermatology.

@article{6086c0e5f3e54543988ed340bb062259,

title = "Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice",

author = "N Wagner and MM Lenders and K Kuhl and L Reinhardt and M Fuchss and N Ring and Georg Richtig and C Ebel and F Andre and R Stager and C Zellweger and SH Sturmer and R Lang and M Paar and P Gussek and S Kimeswenger and A Oellinger and T Amaral and A Forschner and U Leiter-Stoppke and B Weide and M Gassenmaier and A Schraag and B Klumpp and W Hoetzenecker and M Ziemer and C Berking and J Mangana and VA Nguyen and P Terheyden and Erika Richtig and C Loquai and S Diem and A Cozzio and M Rocken and C Garbe and C Gebhardt and F Meier and T Eigentler and L Flatz",

year = "2022",

language = "English",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell Publishing Ltd",

note = "32. Deutscher Hautkrebskongress, ADO 32 ; Conference date: 14-09-2022 Through 17-09-2022",

}

Wagner, N, Lenders, MM, Kuhl, K, Reinhardt, L, Fuchss, M, Ring, N, Richtig, G, Ebel, C, Andre, F, Stager, R, Zellweger, C, Sturmer, SH, Lang, R, Paar, M, Gussek, P, Kimeswenger, S, Oellinger, A, Amaral, T, Forschner, A, Leiter-Stoppke, U, Weide, B, Gassenmaier, M, Schraag, A, Klumpp, B, Hoetzenecker, W, Ziemer, M, Berking, C, Mangana, J, Nguyen, VA, Terheyden, P, Richtig, E, Loquai, C, Diem, S, Cozzio, A, Rocken, M, Garbe, C, Gebhardt, C, Meier, F, Eigentler, T & Flatz, L 2022, 'Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice', JDDG - Journal of the German Society of Dermatology.

TY - JOUR

T1 - Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

AU - Wagner, N

AU - Lenders, MM

AU - Kuhl, K

AU - Reinhardt, L

AU - Fuchss, M

AU - Ring, N

AU - Richtig, Georg

AU - Ebel, C

AU - Andre, F

AU - Stager, R

AU - Zellweger, C

AU - Sturmer, SH

AU - Lang, R

AU - Paar, M

AU - Gussek, P

AU - Kimeswenger, S

AU - Oellinger, A

AU - Amaral, T

AU - Forschner, A

AU - Leiter-Stoppke, U

AU - Weide, B

AU - Gassenmaier, M

AU - Schraag, A

AU - Klumpp, B

AU - Hoetzenecker, W

AU - Ziemer, M

AU - Berking, C

AU - Mangana, J

AU - Nguyen, VA

AU - Terheyden, P

AU - Richtig, Erika

AU - Loquai, C

AU - Diem, S

AU - Cozzio, A

AU - Rocken, M

AU - Garbe, C

AU - Gebhardt, C

AU - Meier, F

AU - Eigentler, T

AU - Flatz, L

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000851869200006

M3 - Conference abstract

SN - 1610-0379

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

T2 - 32. Deutscher Hautkrebskongress

Y2 - 14 September 2022 through 17 September 2022

ER -

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

UN SDGs

Branches of science

Links

Activities

Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

Cite this